Article
A Promising Liposomal Vaccine Candidate Against Epstein–Barr Virus: An In Vitro Evaluation
2025-10-03
Abstract excerpt
Epstein-Barr virus (EBV) is a highly prevalent oncogenic herpesvirus associated with infectious mononucleosis, multiple malignancies and autoimmune disorders. Despite its global disease burden, no licensed vaccine is currently available. In this study, we developed PEGylated liposomes encapsulating full-length gp350 with MPLA adjuvant, systematically modulating DOPC- versus DOPE-based bilayers to reveal how lipid...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bf5e9ecc-efab-5922-b2a9-b8331296e37b
- DOI
- 10.22541/au.175952216.64923020/v1
